[EN] BRUTON'S TYROSINE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA TYROSINE KINASE DE BRUTON
申请人:PFIZER
公开号:WO2014068527A1
公开(公告)日:2014-05-08
Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions. (Formula I)
本文披露了一种与Bruton's酪氨酸激酶(BTK)形成共价键的化合物。公开了制备这些化合物的方法。还披露了包括这些化合物的药物组合物。公开了使用BTK抑制剂的方法,单独或与其他治疗剂联合治疗自身免疫疾病或症状、异源免疫疾病或症状、癌症,包括淋巴瘤,以及炎症性疾病或症状的方法。 (化学式I)